treatment of mice bearing i.p . implants of the ehrlich ascites carcinoma , leukemia l1210/tg8 , and colon carcinoma 26 with potentially lethal dosages of tubercidin administered together with host-protecting dosages of nbmpr-p resulted in substantial kill of neoplastic cells and long-term survivors .
C0699790
colon carcinoma
C0597032
neoplastic cells